← Back

Wire · opportunities

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates ...

Published

11 September 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at biospace.com

Verified

Fusion42 · 11 September 2026 · Fusion42 review

Shoulder Innovations received FDA 510(k) clearance for the N-22 Humeral Head, a titanium implant for metal-sensitive patients, and has started its full commercial launch in the U.S.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

You gain a new FDA-approved implant option to address metal sensitivity in shoulder surgery patients, opening direct access to a niche but growing market of surgeons and operating centres.

Coverage

1 source · 11 Sep 2026

Related on Wire

Topics

Medtechfda-clearancemedical-deviceimplantshoulder-surgerymetal-hypersensitivity